Eduardo Méndez

A 13-Gene Signature Prognostic of HPV-Negative OSCC: Discovery and External Validation

Pawadee Lohavanichbutr, Eduardo Méndez, F. Christopher Holsinger et al. · Clinical Cancer Research · 2013 · 205 citations · Full text

Medicine, Biostatistics, Oncology +17

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Renato Martins, Upendra Parvathaneni, Julie E. Bauman et al. · Journal of Clinical Oncology · 2013 · 202 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Genomewide Gene Expression Profiles of HPV-Positive and HPV-Negative Oropharyngeal Cancer

Pawadee Lohavanichbutr, J. C. Houck, Wenhong Fan et al. · Archives of Otolaryngology - Head and Neck Surgery · 2009 · 119 citations · Full text

Medicine, Oncology, Oral Pathology +17

A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma

Eduardo Méndez, Cristina P. Rodriguez, Michael Kao et al. · Clinical Cancer Research · 2018 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

Transcriptional expression profiles of oral squamous cell carcinomas

Eduardo Méndez, Chun Cheng, D. Gregory Farwell et al. · Cancer · 2002 · 108 citations · Full text

Medicine, Cancer Biology, Oral Pathology +15